Weiler, N; Thrun, I; Eberlin, M et al.
TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION?TRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 255-255
Kunkel, M
"Die Klinische Pharmazie in Belgien"Krankenhauspharmazie. Bd. 31. 2010 S. 147-154
Krämer, I; Kaiser, J; Walz-Jung, H
Bedeutung des Verordnungsmonitorings in der zentralen ZytostatikaherstellungKrankenhauspharmazie. Bd. 31. 2010 S. 349-357
Jekle, C; Kraemer, I
Blister Packages for Objective Therapy Compliance Measurement Validity of an innovative system for compliance measurementPHARMAZEUTISCHE INDUSTRIE. Bd. 72. H. 6. 2010 S. 1070-+
Krämer, I
Comparing echinocandins: a reviewEuropean Journal of Hospital Pharmacy Practice. Bd. 16. 2010 S. 63-67
Weiler, N; Thrun, I; Hoppe-Lotichius, M et al.
Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded TrialTRANSPLANTATION. Bd. 90. H. 12. 2010 S. 1562-1566
Krämer, I; Thiesen, J; Kaiser, J
Stability of irinotecan-loaded drug eluting beads (DC Bead™) used for transarterial chemoembolizationJournal Oncology Pharmacy Practice. 2010 S. 53-61
Kraemer, I; Sauer, T
The new world of biosimilars: what diabetologists need to know about biosimilar insulinsThe british journal of diabets and vascular disease. Bd. 10. 2010 S. 163-171
Krämer, I
Zytostatikaherstellung in der ApothekePharmazie in unserer Zeit. Bd. 39. 2010 S. 280-287
Kunkel, M; Ganso, M; Krämer, I
APOSTAT - eine elektronische Datenbank zur Dokumentation und Analyse der pharmazeutischen Betreuung in der Universitätsmedizin MainzKrankenhauspharmazie. Bd. 30. 2009 S. 156-165